Susan G. Komen Targets $1M Fundraise at Houston Race for the Cure Amid Rising Breast Cancer Cases
Event summary
- Susan G. Komen to host 2026 Houston Race for the Cure on October 3, aiming to raise $1M for breast cancer research and patient support.
- Texas expected to see 24,270 new breast cancer diagnoses in 2026, with 3,400 deaths projected.
- Komen's Patient Care Center provided 2,433 navigation services to 1,690 individuals in Texas in FY 2026.
- Financial Assistance Program distributed $661,500 to 1,339 Texas patients in FY 2026.
- Event sponsored by 29 local and national partners, including Bank of America and MD Anderson Cancer Center.
The big picture
Susan G. Komen's Houston Race for the Cure comes at a critical time as breast cancer diagnoses rise, particularly among women under 50. The organization's comprehensive approach—combining fundraising, patient support, and advocacy—positions it as a key player in addressing healthcare disparities. With 29 sponsors backing the event, Komen demonstrates strong industry collaboration in the fight against breast cancer.
What we're watching
- Fundraising Momentum
- Whether Susan G. Komen can sustain its $1M fundraising target amid rising breast cancer cases and increasing diagnostic rates among younger women.
- Patient Support Scaling
- The pace at which Komen can expand its patient navigation and financial assistance programs to meet growing demand in Texas and other high-incidence regions.
- Research Impact
- How accelerated research funding from events like the Houston Race for the Cure will translate into near-term breakthroughs for metastatic breast cancer treatments.